We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+22.28%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$126M
AUM Growth
+$12.5M
(+11%)
Cap. Flow
+$1.13M
Cap. Flow
% of AUM
0.9%
Top 10 Holdings %
Top 10 Hldgs %
46.68%
Holding
92
New
9
Increased
16
Reduced
49
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Owlet
OWLT
|
+$1.16M |
| 2 |
Neogen
NEOG
|
+$1.13M |
| 3 |
Veritone
VERI
|
+$944K |
| 4 |
PROF
Profound Medical
PROF
|
+$734K |
| 5 |
CPS Technologies
CPSH
|
+$715K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BlackSky Technology
BKSY
|
+$1.83M |
| 2 |
SKYT
SkyWater Technology
SKYT
|
+$632K |
| 3 |
Ciena
CIEN
|
+$601K |
| 4 |
Hain Celestial
HAIN
|
+$335K |
| 5 |
OptimizeRx
OPRX
|
+$330K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 64.31% |
| 2 | Technology | 24.24% |
| 3 | Communication Services | 5.8% |
| 4 | Industrials | 2.52% |
| 5 | Consumer Staples | 1.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Asure Software
ASUR
$248M
| $221K | 0.18% |
23,500
-1,500
| -6% | -$12.6K |
|
77
Costco
COST
$418B
| $216K | 0.17% |
250
| – | – |
|
|
78
OptimizeRx
OPRX
$130M
| $213K | 0.17% |
17,408
-20,188
| -54% | -$330K |
|
79
Tactile Systems Technology
TCMD
$676M
| $205K | 0.16% |
7,066
-7,000
| -50% | -$155K |
|
80
ExxonMobil
XOM
$628B
| $204K | 0.16% |
+1,694
| New | +$196K |
|
|
81
Hain Celestial
HAIN
$50.3M
| $187K | 0.15% |
174,650
-271,563
| -61% | -$335K |
|
82
CVRx
CVRX
$148M
| $115K | 0.09% |
16,150
-3,600
| -18% | -$32.9K |
|
83
Exagen
XGN
$161M
| $113K | 0.09% |
18,575
-1,500
| -7% | -$13.7K |
|
84
Pulmonx
LUNG
$83.6M
| $108K | 0.09% |
49,000
+28,000
| +133% | +$52.6K |
|
85
Airgain
AIRG
$72.5M
| $89.3K | 0.07% |
22,000
-14,500
| -40% | -$58.8K |
|
86
Puma Biotechnology
PBYI
$407M
| $74.4K | 0.06% |
12,500
+300
| +2% | +$1.59K |
|
87
Accuray
ARAY
$32.8M
| $71.3K | 0.06% |
86,500
+15,700
| +22% | +$19.6K |
|
88
Rockwell Medical
RMTI
$28.7M
| $56.6K | 0.04% |
6,787
-405
| -6% | -$4.09K |
|
89
SOPHiA GENETICS
SOPH
$529M
| $49K | 0.04% |
+10,500
| New | +$47.6K |
|
90
IRIDEX
IRIX
$14.7M
| $47.1K | 0.04% |
41,300
| – | – |
|
|
FPAY
91
DELISTED
FlexShopper
FPAY
| $7 | ﹤0.01% |
77,000
-13,550
| -15% | -$4.6K |
|
92
Quest Diagnostics
DGX
$26B
| – | – |
-1,200
| Closed | -$229K |
|
Similar funds
PWP
BF
HWMG
FTEA
WT
BAM
WLG
PA
Perkins Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Perkins Capital Management held 92 positions worth $126M, up 11% from $113M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Perkins Capital Management's Q4 2025 filing shows 9 new, 16 increased, 49 reduced and 1 closed positions. Its largest new stake was Owlet: 102,105 shares worth $1.65M. The largest sale was BlackSky Technology, an estimated $1.83M.
By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 58% a quarter earlier, followed by Technology and Communication Services.
- Perkins Capital Management's largest Q4 2025 buy was Owlet: 102,105 shares worth $1.65M.
- Perkins Capital Management added most to TELA Bio in Q4 2025, an estimated $713K increase.
- Perkins Capital Management's biggest Q4 2025 reduction was BlackSky Technology, cutting an estimated $1.83M.
- Perkins Capital Management fully exited Quest Diagnostics in Q4 2025, selling an estimated $229K.
- Perkins Capital Management's ten largest holdings make up 47% of its $126M portfolio in Q4 2025.
- Perkins Capital Management opened 9 new positions and closed 1 in Q4 2025.
- Perkins Capital Management's portfolio value rose 11% quarter-over-quarter to $126M.
Based on Perkins Capital Management's 13F filing for Q4 2025, filed 4 Feb 2026.